SCYX
Scynexis IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$42.15M
P/E Ratio
—
EPS
$-3.84
Beta
1.12
52W High
$10.48
52W Low
$4.15
50-Day MA
$6.75
200-Day MA
$6.30
Dividend Yield
—
Profit Margin
-120.50%
Forward P/E
3.72
PEG Ratio
0.00
About Scynexis Inc
SCYNEXIS, Inc., a biotechnology company, offers therapies for the treatment of yeast infections in the United States. The company is headquartered in Jersey City, New Jersey.
Fundamentals
| Revenue (TTM) | $20.34M |
| Gross Profit (TTM) | $20.34M |
| EBITDA | $-36.54M |
| Operating Margin | -120.00% |
| Return on Equity | -53.40% |
| Return on Assets | -21.00% |
| Revenue/Share (TTM) | $3.23 |
| Book Value | $0.67 |
| Price-to-Book | 1.02 |
| Price-to-Sales (TTM) | 2.07 |
| EV/Revenue | 0.0596 |
| EV/EBITDA | 0.05 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 1809.00% |
| Shares Outstanding | $9.93M |
| Float | $7.70M |
| % Insiders | 2.10% |
| % Institutions | 42.33% |
Historical Volatility
HV 10-Day
63.54%
HV 20-Day
72.70%
HV 30-Day
73.00%
HV 60-Day
73.61%
HV Rank
65.5%
Volatility is currently contracting
Analyst Ratings
Consensus ($33.55 target)
1
Strong Buy2
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026